Related Experiment Video
Updated: Sep 1, 2025

09:22
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
5.6K
Systematic Functional Analysis of PINK1 and PRKN Coding Variants
Benjamin J Broadway1, Paige K Boneski1, Jenny M Bredenberg1
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Cells
|August 12, 2022
Summary
Researchers analyzed rare genetic variants in PINK1 and PRKN genes, crucial for mitochondrial quality control in Parkinson's disease (PD). Some variants cause loss of function, potentially explaining PD development and aiding future diagnostics and treatments.
Area of Science:
- Genetics and Molecular Biology
- Neuroscience
- Cell Biology
Background:
- Loss-of-function mutations in PINK1 and PRKN genes are linked to early-onset Parkinson's disease (PD).
- PINK1 and PRKN proteins are essential for mitophagy, a process that removes damaged mitochondria.
- The functional significance of many identified genetic variants in these genes remains uncharacterized.
Purpose of the Study:
- To functionally characterize understudied genetic variants in PINK1 and PRKN genes.
- To identify variants with potential causative roles in Parkinson's disease.
- To explore the utility of sensitive functional assays and gene editing for variant analysis.
Main Methods:
- Analysis of twenty variants (ten in PINK1, ten in PRKN), focusing on understudied variants from the Parkinson's Progression Markers Initiative.
- Employment of sensitive assays to assess the enzymatic and functional deficits of these variants.
- Gene editing of midbrain-derived neuronal precursor cells to study specific PINK1 variants (D525N and Q115L).
Main Results:
- Nomination of specific rare PINK1 and PRKN variants demonstrating loss of enzymatic function, suggesting a causative role in PD.
- Identification of several variants exhibiting intermediate functional phenotypes.
- Demonstration of a stability defect for the PINK1 D525N mutation and reduced kinase activity for the common PINK1 Q115L variant in isogenic neurons.
Conclusions:
- Sensitive functional assays can effectively identify pathogenic variants in PINK1 and PRKN.
- This approach aids in understanding the genetic basis of Parkinson's disease.
- Findings support the development of improved diagnostics and targeted therapies for PD.

